MedPath

The Effects of an Anti-inflammatory Diet With or Without Curcumin Supplementation on Anthropometric Measurements, Concentrations of Thyroid Hormones, Anti-TPO, and Systemic Inflammation in Plasma and NFK-B in Peripheral Blood Mononuclear Cells in Patients With Hashimato

Not Applicable
Not yet recruiting
Conditions
Hypothyroidism
Thyroid Diseases
Hashimoto Disease
Interventions
Behavioral: Anti-inflammatory diet
Dietary Supplement: curcumin
Registration Number
NCT05975866
Lead Sponsor
National Nutrition and Food Technology Institute
Brief Summary

The goal of this clinical trial is to investigate The effects of an anti-inflammatory diet with or without curcumin supplementation on anthropometric measurements, concentrations of thyroid hormones, anti-TPO, and systemic inflammation in plasma and NFK-B in peripheral blood mononuclear cells in patients with Hashimoto.

The main questions it aims to answer are:

1. Does prescribing an anti-inflammatory diet with or without curcumin supplementation significantly affect the changes in anthropometric measurements (weight, body mass index, BMI, waist circumference, waist-to-hip ratio) in patients with Hashimoto's disease?

2. Does prescribing an anti-inflammatory diet with or without curcumin supplementation significantly affect the changes in the serum concentration of thyroid hormones (T3, T4, TSH) in patients with Hashimoto's disease?

3. Does prescribing an anti-inflammatory diet with or without curcumin supplementation significantly affect the change of Anti-TPO concentration in patients with Hashimoto's disease?

4. Does prescribing an anti-inflammatory diet with or without curcumin supplementation significantly affect the changes in systemic inflammation indicators (hs-CRP, IL-6) in plasma and NF-κB in peripheral blood mononuclear cells in patients with Hashimoto's disease?

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria

Having Hashimoto's thyroiditis Willingness to cooperate Body mass index between 35 and 18.5 TSH less than ten and without clinical symptoms Not taking levothyroxine tablets

Exclusion Criteria

Pregnancy and breastfeeding kidney Diseases Follow non-routine weight loss diets for three months before the start of the study × Taking slimming and fat-burning drugs, fiber powder Mineral, vegetable, and fiber vitamin supplements

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group receiving anti-inflammatory regimen with curcumin placeboAnti-inflammatory dietImplementation of an anti-inflammatory diet along with the daily consumption of three 500 mg placebo capsules of curcumin (microcrystalline cellulose) and the main meals of breakfast, lunch, and dinner.
The group receiving anti-inflammatory diet with curcumin supplementcurcuminImplementation of an anti-inflammatory diet along with the daily consumption of three 500 mg curcumin capsules along with the main meals of breakfast, lunch, and dinner.
The group receiving anti-inflammatory diet with curcumin supplementAnti-inflammatory dietImplementation of an anti-inflammatory diet along with the daily consumption of three 500 mg curcumin capsules along with the main meals of breakfast, lunch, and dinner.
Primary Outcome Measures
NameTimeMethod
LDL3 month

low-density lipoprotein

waist circumference3 month

waist circumference in Centimeter

HDL3 month

high-density lipoprotein

T43 month

Thyroxine

TSH3 month

Thyroid-stimulating hormone

waist to hip ratio3 month

an Anthropometric index

IL63 month

Interleukin 6

NF-KB3 month

Nuclear factor kappa-light-chain-enhancer of activated B cells

Anti-tpo3 month

antithyroperoxidase

Hb3 month

hemoglobin - Blood test

hip circumference3 month

hip circumference in Centimeter

hs-Crp3 month

high-sensitivity C-reactive protein

Total Cholestrol3 month

serum lipid profile

TG3 month

Triglyceride - serum lipid profile

T33 month

Triiodothyronine

BMI3 month

Body Mass Index - Anthropometric index

hematocrit3 month

Blood test

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Golbon Sohrab

🇮🇷

Tehran, National Nutrition And Food Technology Research Institute, Iran, Islamic Republic of

© Copyright 2025. All Rights Reserved by MedPath